Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

  247,533      
Direct Value   $43,079,680    

Indirect Value

  $21,938,850      
Total Shares   787,387      
Total Value   $65,018,530      


Biomarin Pharmaceutical Inc
 $41,992,185 Neurogesx Inc
 $0 Portola Pharmaceuticals Inc
 $12,729 Immunic Inc
 $23,495 Incyte Corp
 $910,988 Immunome Inc.
 $140,283 Biomarin Pharmaceutical Inc
 $41,992,185 Neurogesx Inc
 $0 Portola Pharmaceuticals Inc
 $12,729 Immunic Inc
 $23,495 Incyte Corp
 $910,988 Immunome Inc.
 $140,283
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    1    

     Stock price went up :

    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

Download
  Page 17 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-12 4 D $67.68 $600,525 D/D (8,873) 102,165 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-12 4/A D $67.68 $591,659 D/D (8,742) 102,165 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-08 4 D $56.78 $311,098 D/D (5,479) 189,756 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-12 4 D $59.30 $270,823 D/D (4,567) 185,189 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-15 4 D $57.44 $283,294 D/D (4,932) 180,257 0 -
ITMN InterMune Inc Director   –       •      –    2014-09-29 4 D $74.00 $630,850 D/D (8,525) 1,200 0 -
ITMN InterMune Inc Director   –       •      –    2014-09-29 4 D $74.00 $88,800 D/D (1,200) 0 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-08 4 D $121.66 $666,575 D/D (5,479) 243,175 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-12 4 D $121.09 $284,440 D/D (2,349) 240,826 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-15 4 D $122.78 $605,551 D/D (4,932) 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-06-04 4 D $120.46 $799,854 D/D (6,640) 229,254 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-02-29 4 D $81.87 $15,799,436 D/D (192,982) 350,500 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-03 4 D $89.57 $805,145 D/D (8,989) 331,511 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-06 4 D $80.80 $442,703 D/D (5,479) 390,156 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-13 4 D $82.71 $407,926 D/D (4,932) 385,224 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-06-03 4 D $90.00 $597,600 D/D (6,640) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-03 4 D $93.95 $844,517 D/D (8,989) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 D $92.50 $1,451,325 D/D (15,690) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-15 4 D $91.50 $451,278 D/D (4,932) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-06-02 4 D $90.72 $602,381 D/D (6,640) 226,924 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-02 4 D $79.86 $682,164 D/D (8,542) 264,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 D $83.57 $1,245,862 D/D (14,908) 249,766 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4 D $81.36 $1,063,782 D/D (13,075) 284,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4/A D $81.36 $1,068,013 D/D (13,127) 283,979 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-06-04 4 D $92.07 $580,962 D/D (6,310) 284,290 0 -

  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17  18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 17 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed